CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  News  /  Media Stories

MEDIA STORIES

Interchangeable insulin to help us compete with big insulin makers: Kiran Mazumdar-Shaw

 29-Aug-2021

external_link-01
Vaccines alone will not protect and make the world safer: Biocon chief

 30-Jul-2021

external_link-01
India must use, share Covid data transparently: Kiran Mazumdar-Shaw

 26-Jul-2021

external_link-01
Biocon partners Adagio for licence to make Covid-19 antibody cocktail

 26-Jul-2021

external_link-01
Biocon eyes market share expansion in developed, emerging markets: Kiran Mazumdar-Shaw

 23-Jul-2021

external_link-01
Biocon Q4 profit more than doubles to Rs 254 crore

 29-Apr-2021

external_link-01
Shreehas Tambe named Deputy CEO of Biocon Biologics

 02-Mar-2021

external_link-01
Biocon Biologics, Viatris get CHMP nod for Abevmy

 02-Mar-2021

external_link-01
Biocon Biologics to partner with International Diabetes Federation

 16-Feb-2021

external_link-01
Biocon arm, CHAI in pact on affordable cancer therapies

 04-Feb-2021

external_link-01
Expect Accelerated Growth from Next Fiscal, Says Kiran Mazumdar-Shaw

 25-Jan-2021

external_link-01
Biocon says may have to delay biologics biz IPO

 25-Jan-2020

external_link-01
PANDEMIC PAIN Biocon Chairperson Kiran Mazumdar-Shaw says the Covid impact on business across the value chain has been larger than expected p2

 25-Jan-2020

external_link-01
Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs

08-Nov-2020

external_link-01
India-based company brings affordable insulin to 2 PH towns

23-Oct-2020

external_link-01
Will Biocon’s COVID-19 anti-inflammatory succeed where IL-6 blockers have failed?

 01-Aug-2020

external_link-01
India’s Biocon secures approval to use drug on coronavirus patients

 11-July-2020

external_link-01
Biosimilar drugs can help us reach $1 billion target soon

16-Jun-2020

external_link-01
Kiran Mazumdar-Shaw named EY World Entrepreneur of 2020

 06-Jun-2020

external_link-01
Covid provides larger opportunity to shape the biosimilar landscape

 19-May-2020

external_link-01
Will invest Rs2,000 crore in small molecules in 3-4 years

 16-May-2020

external_link-01
Biocon wins patent case against Sanofi

 12-Mar-2020

external_link-01
Biocon’s cancer biosimilar gets US FDA acceptance for review

 10-Mar-2020

external_link-01
Biocon chief is EY entrepreneur for 2019

 22-Feb-2020

external_link-01
Biocon Biologics Eyes $200M. Plans IPO in 2 Yrs: Mazumdar-Shaw

 27-Jan-2020

external_link-01
Biocon Q3 PBT up 9%

 24-Jan-2020

external_link-01
Biocon optimistic about hitting $1 billion in revenue by FY22 on back of new launches

 08-Jan-2020

external_link-01
Biocon, partner Mylan launch oncology biosimilar trastuzumab in US

11-Dec-2019

external_link-01
USFDA nod to Biocon’s new Bengaluru unit

28-Nov-2019

external_link-01
Biocon, Mylan get nod for pegfilgrastim drug

28-Nov-2019

external_link-01
Indian company makes it to top 10 best employers in biotech category

30-Oct-2019

external_link-01
Insulin at ₹7 will be a gamechanger for us

26-Oct-2019

external_link-01
Life-enabling product like insulin should be made affordable: Shaw

28-Sep-2019

external_link-01
Biocon plans to halve insulin prices

27-Sep-2019

external_link-01
Biocon sets $1 billion target for biologics business

25-Oct-2019

external_link-01